MJoTA (Medical Journal of Therapeutics Africa)

MiMW (MJoTA Institute of Medical Writing) - Emerald Pademelon Press LLC - MJoTA-NYEcho Partners

MJoTA Portal

Diabetes cinnamon rats

201205 Malaria bad drugs

201205MalariaDrugResistan

201205Malaria vaccine ph1

Diabetes cinnamon EJI

Diabetes cinnamon

Diabetes cinnamon lipids

Diabetes nutmeg

20120517 Coffee NEJM

20120517coffee alzheimers

20120517 Coffee Japan

20120104 NCHS twins

20120104 land of twins

20120194 Igbo twins

20120501 NIH asthma

20120501 Asthma US Africa

20120501 Asthma home

Dr Susanna website

Ganymede Movies LLP

Registration page

20111229 asd cdc

20111229 Autism video

20111229 MMWR

MJoTA.org resources 2011

Vaccinations

Diabetes

Diabetes CME resources

Diabetes Podcasts

Amer J Diabetes

Malaria

Malaria Podcasts

Liver

HIV/AIDS

HIV/AIDS Podcasts

BI HIV drug

CDC HIV

Cancer

Cancer Podcasts

Tuberculosis

Daily Updates

MiMW Certificate

MiMW

Calendar

MiMW Resources

MJoTAtalks: Health

MJoTA pages

Search page

MJoTA masthead

Author guidelines

MJoTA publications

Front covers

MJoTA 2011

MJoTA 2010

MJoTA 2009

MJoTA 2008

MJoTA 2007

MJoTA Mentors

homework Dec 09

MJoTA Presenting yourself

Job Fair

Regulatory doc files

Protocols

Indian drugs resources

Indian drug regulations

Kenya drug regs

Nigerian drug regs

Libya

Book concept to shelf

Health Audio Podcasts

Caribbean Health Podcasts

African Health Dialogues

African Health Podcasts

Child Health Podcasts

Contact us

Tropical diseases movies

 
Loading

Post-treatment haemolysis in severe imported malaria after intravenous artesunate: case report of three patients with hyperparasitaemia.

Rolling T, Schmiedel S, Wichmann D, Wittkopf D, Burchard GD, Cramer JP. Malar J. 2012 May 17;11(1):169.

Abstract

ABSTRACT: Parenteral artesunate has been shown to be a superior treatment option compared to parenteral quinine in adults and children with severe malaria. Little evidence, however, is available on long-term safety. Recently, cases of late-onset haemolysis after parenteral treatment with artesunate have been reported in European travellers with imported Plasmodium falciparum malaria. Therefore, an extended follow-up of adult patients treated for severe imported malaria was started in August 2011 at the University Medical Center Hamburg-Eppendorf. Until January 2012, three patients with hyperparasitaemia (range: 14-21%) were included for analysis. In all three patients, delayed haemolysis was detected in the second week after the first dose of intravenous artesunate. Reticulocyte production index remained inadequately low in the 7 - 14 days following the first dose of artesunate despite rapid parasite clearance. Post-treatment haemolysis after parenteral artesunate may be of clinical relevance in particular in imported severe malaria characterized by high parasite levels. Extended followup of at least 30 days including controls of haematological parameters after artesunate treatment seems to be indicated. Further investigations are needed to assess frequency and pathophysiological background of this complication.


MJoTA.org. Published since 2006 by Emerald Pademelon Press LLC. PO Box 381 Haddonfield, NJ 08033, USA. 1-609-792-1571. Publisher@mjota.org